Rankings
▼
Calendar
PMVP
PMV Pharmaceuticals, Inc.
$84M
Q3 2019 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$6M
Net Income
-$6M
EPS (Diluted)
$-0.20
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$6M
Free Cash Flow
-$6M
Stock-Based Comp.
$239,000
← FY 2019
All Quarters
Q4 2019 →
PMVP Q3 2019 Earnings — PMV Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena
